Invites Biocore Co., Ltd. (XKON:216400)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,090.00
-40.00 (-0.97%)
At close: Feb 13, 2026
Market Cap31.54B -26.3%
Revenue (ttm)16.96B +96.2%
Net Income667.63M
EPS163.00
Shares Out7.71M
PE Ratio25.09
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume152
Average Volume835
Open4,125.00
Previous Close4,130.00
Day's Range3,700.00 - 4,125.00
52-Week Range1,801.00 - 6,600.00
Beta0.18
RSI46.34
Earnings Daten/a

About Invites Biocore

Invites Biocore Co., Ltd. provides bioanalytical and central lab services in South Korea and internationally. It offers bioanalytical testing service during biological equivalence tests, clinical trials, toxicokinetics, nonclinical trials, vivo dynamic analysis, comparative dissolution test, and biomarker analysis; provides project strategic planning, medical translation, clinical research, quality assurance, monitoring, and data management for clinical services; and offers services, such as pharmaceutical quality control testing, emergency tes... [Read more]

Industry Testing Laboratories
Founded 2001
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 216400
Full Company Profile

Financial Performance

In 2014, Invites Biocore's revenue was 16.96 billion, an increase of 29.35% compared to the previous year's 13.11 billion. Earnings were 667.63 million, a decrease of -17.76%.

Financial Statements